Differential effects of thapsigargin analogues on apoptosis of prostate cancer cells

Engineering a Prostate-Specific Membrane Antigen-Activated Tumor Endothelial Cell Prodrug for Cancer Therapy

(2012) S. R. Denmeade et al.   Science Translational Medicine

Activated Protein CN-Linked Glycans Modulate Cytoprotective Signaling Function on Endothelial Cells

(2010) Fionnuala Ní Áinle et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Critical Roles of Hydrophobicity and Orientation of Side Chains for Inactivation of Sarcoplasmic Reticulum Ca2+-ATPase with Thapsigargin and Thapsigargin Analogs

(2010) Anne-Marie L. Winther et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Calcium-dependent phospholipid scrambling by TMEM16F

(2010) Jun Suzuki et al.   NATURE

Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells

(2010) M Flourakis et al.   Cell Death & Disease

STIM and Orai: Dynamic Intermembrane Coupling to Control Cellular Calcium Signals

(2009) Xiaoxiang Deng et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells

(2009) D. J. Vander Griend et al.   MOLECULAR CANCER THERAPEUTICS

Intracellular death platform steps-in: Targeting prostate tumors via endoplasmic reticulum (ER) apoptosis

(2008) Steven R. Schwarze et al.   PROSTATE